Xtant Medical Holdings
XTNT
22 hedge funds and large institutions have $45.2M invested in Xtant Medical Holdings in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 0 closing their positions.
29% more funds holding
Funds holding: 17 → 22 (+5)
0.08% more ownership
Funds ownership: 92.85% → 92.93% (+0.08%)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
49% less capital invested
Capital invested by funds: $89.4M → $45.2M (-$44.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CGA
Crescent Grove Advisors
Lake Forest,
Illinois
|
+$153K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$42.1K |
| 3 |
Renaissance Technologies
New York
|
+$38.4K |
| 4 |
VF
Virtu Financial
New York
|
+$31.5K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$21.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$117K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$20.2K |
| 3 |
ACM
Altium Capital Management
New York
|
-$7.7K |
| 4 |
HF
HRT Financial
New York
|
-$6.84K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.83K |
XTNT Hedge Fund Activity: Q4 2021 in Review
22 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q4 2021, worth a combined $45.2M — down 49% from $89.4M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new XTNT positions and 0 closed out — a net gain of 5 holders — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Crescent Grove Advisors, opening a new position worth an estimated $153K. The largest seller was Bridgeway Capital Management, cutting an estimated $117K.
- 22 institutional investors held Xtant Medical Holdings (XTNT) as of Q4 2021, up from 17 in Q3 2021.
- Funds reported $45.2M of Xtant Medical Holdings stock for Q4 2021, down 49% quarter-over-quarter.
- 5 funds opened new Xtant Medical Holdings positions in Q4 2021 and 0 closed out, a net change of +5 holders.
- The largest Xtant Medical Holdings buyer in Q4 2021 was Crescent Grove Advisors, an estimated $153K added.
- The largest Xtant Medical Holdings seller in Q4 2021 was Bridgeway Capital Management, an estimated $117K sold.
Based on aggregated 13F filings for Q4 2021.